Martijn C. Verbeek
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
The impact of scaRNA12 deregulation on p53-mediated cellular stress response in B-cell precursor acute lymphoblastic leukaemia.
Journal: British journal of haematology
Published: February 28, 2025
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study.
Journal: HemaSphere
Published: September 25, 2024
The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia.
Journal: International journal of molecular sciences
Published: March 29, 2024
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study.
Journal: Cytometry. Part B, Clinical cytometry
Published: December 23, 2022
Dysregulation of Small Nucleolar RNAs in B-Cell Malignancies.
Journal: Biomedicines
Published: April 29, 2022
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Journal: British journal of haematology
Published: September 24, 2021
Showing 1-6 of 6
Last Updated: 09/26/2026